Article Sidebar

Submitted
Feb 13, 2020
Published
May 1, 2021
Download
Pdf
Statistic
Read Counter : 856 Download : 3105

Downloads

Download data is not yet available.

Main Article Content

Abstract

Antibiotics are therapies used in cases of infection. Inappropriate use of antibiotics will cause the impact of resistance. Antibiotic use studies need to be done as a step to reduce this impact. The purpose of this study was to determine the practice of using antibiotics by measuring the quantity using the Defined Daily Dose (DDD) and DU90% method in inpatients with a diagnosis of Community-Acquired Pneumonia (CAP) at PKU Muhammadiyah Gamping Hospital. This study is a retrospective study on inpatients of PKU Muhammadiyah Gamping Hospital in 2016-2018. Data was obtained from patient medical records. The results showed a change in the pattern of antibiotic used in 2016-2018. Ceftriaxone and ceftazidime are the most widely used antibiotics. Ceftriaxone with a DDD value of 12.59; 22.49; 23.53 / 100 bed-days and ceftazidime with a DDD value of 17.09; 12.98; 10.59 / 100 bed-days. Antibiotics that are included in DU 90% are Ceftriaxone, Ceftazidime, Cefixime and Levofloxacine. The conclusion of this study is that there is a change in the pattern of antibiotic use in cases of Community-Acquired Pneumonia (CAP) in 2016-2018.


 

Keywords

Antibiotic Community Acquired Pneumonia Defined Daily Dose DU90%

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

  1. Ambami, S. (2020). Evaluasi Penggunaan Antibiotik dengan Metode ATC/DDD pada Pasien Pneumonia di RSUD Jombang Periode Januari-Desember 2019 Etheses of Maulana Malik Ibrahim State Islamic University. http://etheses.uin-malang.ac.id/19089/
  2. Elvina, R., Rahmi, N., & Oktavira, S. A. (2018). Evaluasi Penggunaan Antibiotik pada Pasien Community-Acquired Pneumonia (CAP) di Instalasi Rawat Inap Rumah Sakit “X” Jakarta. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 14(1), 64–74.
  3. Figueiredo-Mello, C., Naucler, P., Negra, M. D., & Levin, A. S. (2018). Ceftriaxone versus ceftriaxone plus a macrolide for community-acquired pneumonia in hospitalized patients with HIV/AIDS: A randomized controlled trial. Clinical Microbiology and Infection, 24(2), 146–151. https://doi.org/10.1016/j.cmi.2017.06.013
  4. Hasegawa, S., Shiraishi, A., Yaegashi, M., Hosokawa, N., Morimoto, K., & Mori, T. (2019). Ceftriaxone versus ampicillin/sulbactam for the treatment of aspiration-associated pneumonia in adults. Journal of Comparative Effectiveness Research, 8(15), 1275–1284. https://doi.org/10.2217/cer-2019-0041
  5. Kemenkes. (2018). Laporan Hasil Riset Kesehatan Dasar (Riskesdas) | Badan Penelitian dan Pengembangan Kesehatan. https://www.litbang.kemkes.go.id/laporan-riset-kesehatan-dasar-riskesdas/
  6. Muhammad, O. R., & Mutmainah, N. (2018). Evaluasi Penggunaan Antibiotik dengan Metode ATC/DDD pada Pasien Pneumonia di Instalasi Rawat Inap RSUD Dr. Moewardi Tahun 2017 (Doctoral dissertation, Universitas Muhammadiyah Surakarta).
  7. Nugroho, F., Utami, P. I., & Astuti, I. Y. (2011). Evaluasi Penggunaan Antibiotik Pada Penyakit Pneumonia Di Rumah Sakit Umum Daerah Purbalingga. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 8(01), Article 01. https://doi.org/10.30595/pji.v8i1.603
  8. Olson, G., & Davis, A. M. (2020). Diagnosis and Treatment of Adults With Community-Acquired Pneumonia. JAMA, 323(9), 885. https://doi.org/10.1001/jama.2019.21118
  9. Prakoso, D., Posangi, J., & Nangoy, E. (2018). Gambaran dan Rasionalitas Penggunaan Antibiotik pada Pasien Dewasa dengan Community Acquired Pneumonia di RSUP Prof. Dr. R. D. Kandou Manado Periode Juni 2017-Mei 2018. EBiomedik, 6(2), Article 2. https://doi.org/10.35790/ebm.6.2.2018.22156
  10. Prananingtyas, A. (2017). Evaluasi Terapi Penggunaan Antibiotik Pada Pasien Pneumonia Rawat Inap Di Rumah Sakit Khusus Paru Respira Yogyakarta Tahun 2015. http://repository.umy.ac.id/handle/123456789/15538
  11. Prasetyo, E. Y., & Kusumaratni, D. A. (2019). Evaluasi Penggunaan Antibiotik Pada Pasien Pneumonia Rawat Inap Di Rs Dkt Kota Kediri Dengan Metode Atc-Ddd Tahun 2018. Prosiding Artikel Seminar Nasional Farmasi, 0(0), Article 0. https://prosidingonline.iik.ac.id/index.php/semfarm/article/view/124
  12. Putri, R. M., & Hasan, H. (2014). Tinjauan Imunologi Pneumonia pada Pasien Geriatri. Cermin Dunia Kedokteran, 41(1), 14–18.
  13. Sama, I. and Mutmainah, N. (2018) ‘Evaluasi Penggunaan Antibiotik Pada Pasien Community-Acquired Pneumonia Rawat Inap Di Rsud Dr. Moewardi Tahun 2016’. Universitas Muhammadiyah Surakarta.
  14. Torres, A., Peetermans, W. E., Viegi, G., & Blasi, F. (2013). Risk factors for community-acquired pneumonia in adults in Europe: A literature review. Thorax, 68(11), 1057–1065. https://doi.org/10.1136/thoraxjnl-2013-204282
  15. Utami, E. R. (2011). Antibiotika, Resistensi, Dan Rasionalitas Terapi. El-Hayah : Jurnal Biologi, 1(4), Article 4. https://doi.org/10.18860/elha.v1i4.1783
  16. Wulandari, D. N. (2016). Efektivitas Penggunaan Antibiotik Ceftriaxone Pada Pasien Pneumonia Dewasa Di Instalasi Rawat Inap Rsud Dr. Moewardi Surakarta Tahun 2014—2015. https://digilib.uns.ac.id/dokumen/54482/Efektivitas-Penggunaan-Antibiotik-Ceftriaxone-Pada-Pasien-Pneumonia-Dewasa-Di-Instalasi-Rawat-Inap-Rsud-Dr-Moewardi-Surakarta-Tahun-2014-2015